Clinical Trials Sponsored by Guangxi Minzu Hospital

Total 401 results

Wei Jiang
Wuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital of Baise and other collaborators

Unknown

Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guangxi Medical University
People's Hospital of Guangxi; Guangxi Sci-Tech Office

Completed

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
People's Hospital of Guangxi

Unknown

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer

Small Cell Lung Cancer

China
People's Hospital of Guangxi

Unknown

Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Cancer Hospital of Guangxi Medical University

Recruiting

Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Sintilimab

China
Cancer Hospital of Guangxi Medical University

Active, not recruiting

Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma

TACE | Lenvatinib | Tislelizumab | Advanced Unresectable Hepatocellular Carcinoma

China
Guangxi Zhuang Autonomous Region People's Hospital

Recruiting

Anlotinib for Hepatocellular Carcinoma (AFHC)

Liver Neoplasms

China
Cancer Hospital of Guangxi Medical University

Unknown

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Hepatocellular Carcinoma

China
Hui Lin

Unknown

Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2

Lung Adenocarcinoma Patients With Postoperative in pN2

China
Cancer Hospital of Guangxi Medical University

Recruiting

Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Nasopharyngeal Carcinoma | Recurrent Nasopharyngeal Squamous Cell Carcinoma | Toripalimab

China
Cancer Hospital of Guangxi Medical University

Recruiting

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma

China
Cancer Hospital of Guangxi Medical University

Unknown

Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University

Unknown

The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma

Effects of Chemotherapy

China
Sun Yat-sen University
Cancer Hospital of Guangxi Medical University; First Affiliated Hospital of... and other collaborators

Enrolling by invitation

Treatments for Brain Metastases With Poor Prognostic Factors (TBMPPF)

Brain Metastases

China
Peking University Third Hospital
People's Hospital of Guangxi

Recruiting

Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia

Presbyopia | Cataract Senile

China
People's Hospital of Guangxi
Liuzhou Workers Hospital; Cancer Hospital of Guangxi Medical University; First... and other collaborators

Not yet recruiting

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

Glioblastoma

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Type2diabetes

China
First Affiliated Hospital of Guangxi Medical University

Completed

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

NMO Spectrum Disorder | Azathioprine Adverse Reaction

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

Beta Thalassemia Major

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University

Unknown

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

Esophageal Cancer
First Affiliated Hospital of Guangxi Medical University

Unknown

A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma

Biliary Carcinoma

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guilin Medical University, China
Wuzhou Red Cross Hospital; Guangxi Naxishan Hospital; National Hospital of Guangxi...

Unknown

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Rectal Cancer | Rectal Cancer Stage II | Rectal Cancer Stage III

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Colonic Neoplasms | Neoadjuvant Therapy | Immune Checkpoint Inhibitors

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Hepatocellular Carcinoma Non-resectable | Immune Checkpoint Inhibitors | Portal Vein Tumor Thrombus

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

CRUSTAL Study in China

Coronary Artery Disease | Calcification

China
Fourth Affiliated Hospital of Guangxi Medical University

Recruiting

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Uterine Cervical Neoplasms | Adjuvant Chemotherapy | Chemoradiotherapy

China
Second Affiliated Hospital of Guangxi Medical University

Not yet recruiting

Safety and Efficacy of Evolocumab in Ischemic Stroke (SEEIS)

Ischemic Stroke, Acute
First Affiliated Hospital of Guangxi Medical University

Recruiting

Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic Neuritis

Optic Neuritis

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Cervical Cancer

China
First Affiliated Hospital of Guangxi Medical University

Completed

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First Affiliated Hospital of Guangxi Medical University

Terminated

Gypenosides Treatment for Optic Neuritis

Optic Neuritis

China
First Affiliated Hospital of Guangxi Medical University

Unknown

Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC

Non-small Cell Lung Cancer
First Affiliated Hospital of Guangxi Medical University

Unknown

Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major

Thalassemia Major

China
People's Hospital of Guangxi
Wu Jieping Medical Foundation

Unknown

Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer

Locally Advanced Cervical Cancer

China
Jiangxi Provincial Cancer Hospital

Not yet recruiting

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Maintenance Therapy | High-Risk Cancer
Jiangxi Provincial Cancer Hospital

Recruiting

Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma (NPC-CR01)

Oligometastatic Disease

China
Jiangxi Provincial Cancer Hospital

Recruiting

A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast

Triple-Negative Breast Cancer

China
Jiangxi Provincial Cancer Hospital

Completed

Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients

Thyroid Neoplasms

China
xiaoliang Huang

Recruiting

FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues

Colorectal Cancer | Monkey Pox

China
Jiangxi Provincial Cancer Hospital

Recruiting

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangxi Provincial Cancer Hospital

Recruiting

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Nasopharyngeal Carcinoma | Tumor Microenvironment | Pathologic Complete Response

China
Jiangxi Provincial Cancer Hospital

Recruiting

High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor (ST-CR01)

Metastatic Cancer

China
Jiangxi Provincial Cancer Hospital

Recruiting

Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangxi Provincial Cancer Hospital

Not yet recruiting

Thalidomide With or Without Probiotics in Radioactive Oral Mucositis

Quality of Life | Oral Mucositis

China
Jiangxi Provincial Cancer Hospital

Completed

Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer

Thyroid Neoplasms
Guangfu Dang

Completed

Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status

Primary Angle Closure Glaucoma

China

Clinical Trials Sponsored by Guangxi Minzu Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations